A multiple cavity malignancy involving the renal capsule, pleura and meninges: A case report and review of the literature

Zhu,Li‑Jing; Liu,Bao‑Rui; Qian,Xiao‑Ping; Kong,Wei‑Wei; Hu,Wen‑Jing; Du,Juan; Zhu,Hai‑Qing

doi:10.3892/ol.2013.1451

September 2013 Volume 6 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September 2013 Volume 6 Issue 3

Full Size Image

Case Report

A multiple cavity malignancy involving the renal capsule, pleura and meninges: A case report and review of the literature

Authors:
- Li‑Jing Zhu
- Bao‑Rui Liu
- Xiao‑Ping Qian
- Wei‑Wei Kong
- Wen‑Jing Hu
- Juan Du
- Hai‑Qing Zhu
View Affiliations / Copyright

Affiliations: The Comprehensive Cancer Center, Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu 2l0008, P.R. China, Department of Pathology, Nanjing Brain Hospital, Nanjing, Jiangsu 2l0029, P.R. China
Pages: 709-712
|
Published online on: July 9, 2013

https://doi.org/10.3892/ol.2013.1451
Expand metrics +

Abstract

Malignant renal subcapsular effusions commonly arise from primary or metastatic renal neoplasms. The current case report presents a rare case of malignancy with a massive renal subcapsular effusion accompanied by a malignant pleural effusion of an unknown primary site, which underwent progression to carcinomatous meningitis during chemotherapy. The type of adenocarcinoma present was determined by effusion cytology. Intravenous chemotherapy (docetaxel plus oxaliplatin and gemcitabine plus cisplatin) were administered; however, the disease still progressed. Time to progression was 9 months during treatment of gefitinib. Comprehensive therapies, including intracavity chemotherapy, immunotherapy and gefitinib, were shown to be effective and prolonged the patient's survival time.

View Figures

View References

1	Pavlidis N, Briasoulis E, Hainsworth J and Greco FA: Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 39:1990–2005. 2003. View Article : Google Scholar : PubMed/NCBI
2	Hainsworth JD and Greco FA: Treatment of patients with cancer of an unknown primary site. N Engl J Med. 329:257–263. 1993. View Article : Google Scholar : PubMed/NCBI
3	Morris GJ, Greco FA, Hainsworth JD, et al: Cancer of unknown primary site. Semin Oncol. 37:71–79. 2010. View Article : Google Scholar : PubMed/NCBI
4	Kendall AR, Senay BA and Coll ME: Spontaneous subcapsular renal hematoma: diagnosis and management. J Urol. 139:246–250. 1988.PubMed/NCBI
5	McDougal WS, Kursh ED and Persky L: Spontaneous rupture of the kidney with perirenal hematoma. J Urol. 114:181–184. 1975.PubMed/NCBI
6	Demos TC, Schiffer MS and Reynes CJ: Metastatic leiomyosarcoma of the kidney with spontaneous perirenal hemorrhage. Diagn Imaging Clin Med. 53:87–90. 1984.PubMed/NCBI
7	Hainsworth JD and Greco A: Neoplasms of unknown primary site. Holland-Frei Cancer Medicine. Bast RC Jr, Kufe DW, Pollock RE, et al: 5th edition. BC Decker; Hamilton, ON, Canada: pp. 2114–2124. 2000
8	Golfinopoulos V, Pentheroudakis G, Salanti G, et al: Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Cancer Treat Rev. 35:570–573. 2009. View Article : Google Scholar : PubMed/NCBI
9	Greco FA, Erland JB, Morrissey LH, et al: Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin. Ann Oncol. 11:211–215. 2000. View Article : Google Scholar : PubMed/NCBI
10	Greco FA, Burris HA III, Litchy S, et al: Gemcitabine, carboplatin and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study. J Clin Oncol. 15:1651–1656. 2002. View Article : Google Scholar : PubMed/NCBI
11	El-Rayes BF, Shields AF, Zalupski M, et al: A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary. Am J Clin Oncol. 28:152–156. 2005. View Article : Google Scholar : PubMed/NCBI
12	Briasoulis E, Kalofonos H, Bafaloukos D, et al: Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol. 18:3101–3107. 2000.PubMed/NCBI
13	Hainsworth JD, Spigel DR, Clark BL, et al: Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial. Cancer J. 16:70–75. 2010. View Article : Google Scholar
14	Grant R, Naylor B, Greenberg HS and Junck L: Clinical outcome in aggressively treated meningeal carcinomatosis. Arch Neurol. 51:457–461. 1994. View Article : Google Scholar : PubMed/NCBI
15	Jayson GC and Howell A: Carcinomatous meningitis in solid tumours. Ann Oncol. 7:773–786. 1996. View Article : Google Scholar : PubMed/NCBI
16	Pavlidis N, Briassoulis E, Bai M, et al: Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin. Anticancer Res. 15:2563–2567. 1995.PubMed/NCBI
17	Fukuoka M, Yano S, Giaccone G, et al: Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. J Clin Oncol. 21:2237–2246. 2003.
18	Massard C, Voigt JJ, Laplanche A, et al: Carcinoma of an unknown primary: are EGF receptor, Her-2/neu and c-Kit tyrosine kinases potential targets for therapy? Br J Cancer. 97:857–861. 2007.PubMed/NCBI
19	Kris MG, Natale RB, Herbst RS, et al: Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA. 290:2149–2158. 2003. View Article : Google Scholar : PubMed/NCBI
20	Hainsworth JD, Spigel DR, Farley C, et al; Minnie Pearl Cancer Research Network. Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network. J Clin Oncol. 25:1747–1752. 2007. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

A multiple cavity malignancy involving the renal capsule, pleura and meninges: A case report and review of the literature

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles